Bristol Myers Squibb gets European Commission nod for Opdivo plus Yervoy for Hepatocellular Carcinoma Ruchika Sharma9 March 2025 12:30 PM ISTPrinceton: Bristol Myers Squibb has announced that the European Commission (EC) has approved Opdivo (nivolumab) plus Yervoy (ipilimumab) for the...
Bristol Myers Squibb application for Opdivo Plus Yervoy for MSI-H/ dMMR colorectal cancer accepted by USFDA Ruchika Sharma27 Feb 2025 12:46 PM ISTBristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental biologics license application...
Injectable version of Bristol Myers Squibb cancer drug Opdivo gets USFDA okay Ruchika Sharma28 Dec 2024 12:30 PM ISTOpdivo Qvantig offers a faster delivery for patients to receive this immunotherapy treatment option in three to five minutes compared to 30 minute IV...
Bristol Myers Squibb gets European Commission nod for Opdivo plus Yervoy to treat colorectal cancer Ruchika Sharma25 Dec 2024 4:52 PM ISTPrinceton: Bristol Myers Squibb has announced that the European Commission (EC) has approved Opdivo (nivolumab) plus...
Bristol Myers Squibb gets positive CHMP opinion for Opdivo plus Yervoy to treat adult with MSI-H or dMMR metastatic Colorectal Cancer Ruchika Sharma18 Nov 2024 4:57 PM ISTPrinceton: Bristol Myers Squibb has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines...
Delhi HC upholds Bristol Myers' patent for anti-cancer drug Dasatinib, imposes Rs 5L penalty on SP Labs Farhat Nasim9 Nov 2024 5:40 PM ISTNew Delhi: In relief to Bristol-Myers Squibb Holdings Ireland (BMS), the Delhi High Court has upheld its patent for the anti-cancer drug dasatinib and...
USFDA nod to Perioperative treatment of Neoadjuvant Opdivo, Chemotherapy followed by Surgery, Adjuvant Single Agent Opdivo for Resectable Non Small Cell Lung Cancer Ruchika Sharma5 Oct 2024 1:25 PM ISTPrinceton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has approved Opdivo (nivolumab) for the...
USFDA approves Bristol Myers Squibb Cobenfy for Schizophrenia treatment in adults Ruchika Sharma29 Sept 2024 10:00 AM ISTPrinceton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has approved COBENFY (xanomeline and trospium...
USFDA accepts application for Opdivo plus Yervoy for unresectable hepatocellular carcinoma Ruchika Sharma22 Aug 2024 4:30 PM ISTPrinceton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental Biologics License...
Bristol Myers Squibb India Gets CDSCO Panel Nod to Study anticancer drug Mezigdomide Dr. Divya Colin17 Aug 2024 6:00 PM ISTNew Delhi: The drug major Bristol-Myers Squib has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Cipla beats Q1 profit view on robust demand Ruchika Sharma27 July 2024 3:07 PM ISTHyderabad: Drugmaker, Cipla, has exceeded profit expectations for the first quarter of the fiscal year, driven by a significant increase in sales...
Bristol Myers Squibb gets EMA validation of application for Opdivo plus Yervoy for Hepatocellular Carcinoma Ruchika Sharma21 July 2024 3:30 PM ISTPrinceton: Bristol Myers Squibb has announced that the European Medicines Agency (EMA) has validated its Type II variation application for...
